Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03205176
Title Phase I Study of AZD5153 in Patients With Relapsed or Refractory Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.